SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-19-000099
Filing Date
2019-01-04
Accepted
2019-01-04 08:12:08
Documents
3
Period of Report
2019-01-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT mbvx_8k.htm 8-K 30875
2 EXHIBIT 99.1 mbvx_ex991.htm EX-99.1 21734
3 IMAGE mbvx_ex991000.jpg GRAPHIC 8720
  Complete submission text file 0001654954-19-000099.txt   65990
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37861 | Film No.: 19508430
SIC: 2834 Pharmaceutical Preparations